1. Pagliaro, L. A. and Benet, L. Z. (1975), Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references. J. Pharmacokin. Bio-pharm.,3, 333–383.
2. Lauberberg, B. and Bircher, J. (1973), Hepatic microsomal drug metabolizing capacity measured in vivo by breath analysis. Gastroenterology,65, 556 (abstract).
3. Schneider, J. F., Schoeller, D. A., Nemchausky, B., Boyer, J. L. and Klein, P. D. (1975), Breath analysis of13C02 following N-demethylation of13C-dimethyl-amino-pyrine. A measure of liver microsomal function. Gastroenterology,69, 865 (abstract).
4. Tygstrup, N. (1964), The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med. Scand.,175, 281–289.
5. Tengström, B. (1966), An intravenous galactose tolerance test with an(1)enzymatic determination of galactose: a comparison with other diagnostic aids in hepatobiliary diseases. Scand. J. Clin. Lab. Invest. (Suppl.),92, 132–142.